Table 3.

Summary of differences in change in analytic morphomics for steroid exposure over the study interval

Subgroup: corticosteroid exposure	No steroid treatment	IQR Min	IQR Max	Steroid treatment	IQR Min	IQR Max	P-value
Change (T0–T1)
∆Pectoralis CSA in cm2	1.01	− 4.03	5.70	− 0.06	− 3.67	4.50	0.691
∆Pectoralis HU	− 2.00	− 7.88	3.12	− 5.98	− 10.82	0.45	0.127
∆Erector spinae CSA in cm2	1.97	− 3.90	7.88	3.72	− 1.59	8.06	0.464
∆Erector spinae HU	− 4.42	− 8.62	1.85	− 2.93	− 8.70	4.59	0.786
∆Subcutaneous fat CSA T12 in cm2	11.02	− 5.62	22.14	15.04	− 0.84	29.01	0.325
∆Visceral fat CSA T12 in cm2	6.57	− 23.96	34.02	24.37	− 6.41	45.12	0.49
∆Visceral fat CSA LMCO in cm2	2.69	− 0.61	13.27	− 0.10	− 11.49	8.83	0.187

This table represents the change in the specified variable between T0 and T1 represented as median change with interquartile range and variable metric according to parameter specification. The p-value relates to a Wilcoxon Ranks test conducted between the median values of the two groups